These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 27586957)
1. FRET-based detection of isozyme-specific activities of transglutaminases. Tatsukawa H; Liu HH; Oba S; Kamiya N; Nakanishi Y; Hitomi K Amino Acids; 2017 Mar; 49(3):615-623. PubMed ID: 27586957 [TBL] [Abstract][Full Text] [Related]
2. Development of peptide-based biosensors for detecting cross-linking and deamidation activities of transglutaminases. Tatsukawa H; Aoyama R; Hitomi K Amino Acids; 2023 Jun; 55(6):807-819. PubMed ID: 37165293 [TBL] [Abstract][Full Text] [Related]
3. Distribution of transglutaminase family members in mouse whole body sections. Tatsukawa H; Abe N; Ohashi S; Hitomi K Biochem Biophys Res Commun; 2015 Nov; 467(4):1046-51. PubMed ID: 26456644 [TBL] [Abstract][Full Text] [Related]
4. Global identification and analysis of isozyme-specific possible substrates crosslinked by transglutaminases using substrate peptides in mouse liver fibrosis. Tatsukawa H; Tani Y; Otsu R; Nakagawa H; Hitomi K Sci Rep; 2017 Mar; 7():45049. PubMed ID: 28327670 [TBL] [Abstract][Full Text] [Related]
5. Identification of a highly reactive substrate peptide for transglutaminase 6 and its use in detecting transglutaminase activity in the skin epidermis. Fukui M; Kuramoto K; Yamasaki R; Shimizu Y; Itoh M; Kawamoto T; Hitomi K FEBS J; 2013 Mar; 280(6):1420-9. PubMed ID: 23331848 [TBL] [Abstract][Full Text] [Related]
7. Variations in both TG1 and TG2 isozyme-specific in situ activities and protein expressions during mouse embryonic development. Itoh M; Tatsukawa H; Eun-Seo L; Yamanishi K; Kojima S; Hitomi K J Histochem Cytochem; 2013 Nov; 61(11):793-801. PubMed ID: 23896968 [TBL] [Abstract][Full Text] [Related]
8. Engineered, highly reactive substrates of microbial transglutaminase enable protein labeling within various secondary structure elements. Rachel NM; Quaglia D; Lévesque É; Charette AB; Pelletier JN Protein Sci; 2017 Nov; 26(11):2268-2279. PubMed ID: 28857311 [TBL] [Abstract][Full Text] [Related]
9. Transglutaminase 2 and Factor XIII catalyze distinct substrates in differentiating osteoblastic cell line: utility of highly reactive substrate peptides. Watanabe K; Tsunoda K; Itoh M; Fukui M; Mori H; Hitomi K Amino Acids; 2013 Jan; 44(1):209-14. PubMed ID: 22045386 [TBL] [Abstract][Full Text] [Related]
10. Phage-displayed peptide library screening for preferred human substrate peptide sequences for transglutaminase 7. Kuramoto K; Yamasaki R; Shimizu Y; Tatsukawa H; Hitomi K Arch Biochem Biophys; 2013 Sep; 537(1):138-43. PubMed ID: 23876241 [TBL] [Abstract][Full Text] [Related]
11. Assessment of expression and specific activities of transglutaminases TG1, TG2, and FXIII-A during osteoclastogenesis. Sun H; Kaartinen MT Anal Biochem; 2020 Feb; 591():113512. PubMed ID: 31786225 [TBL] [Abstract][Full Text] [Related]
12. In situ detection of active transglutaminases for keratinocyte type (TGase 1) and tissue type (TGase 2) using fluorescence-labeled highly reactive substrate peptides. Itoh M; Kawamoto T; Tatsukawa H; Kojima S; Yamanishi K; Hitomi K J Histochem Cytochem; 2011 Feb; 59(2):180-7. PubMed ID: 20876521 [TBL] [Abstract][Full Text] [Related]
13. Substrate preference of transglutaminase 2 revealed by logistic regression analysis and intrinsic disorder examination. Csosz E; Bagossi P; Nagy Z; Dosztanyi Z; Simon I; Fesus L J Mol Biol; 2008 Nov; 383(2):390-402. PubMed ID: 18761350 [TBL] [Abstract][Full Text] [Related]
14. Real-time kinetic method to monitor isopeptidase activity of transglutaminase 2 on protein substrate. Thangaraju K; Biri B; Schlosser G; Kiss B; Nyitray L; Fésüs L; Király R Anal Biochem; 2016 Jul; 505():36-42. PubMed ID: 27131890 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of transglutaminase substrate preference by cDNA display coupled with next-generation sequencing and bioinformatics. Damnjanović J; Odake N; Fan J; Camagna M; Jia B; Kojima T; Nemoto N; Hitomi K; Nakano H Sci Rep; 2022 Aug; 12(1):13578. PubMed ID: 35945258 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of substrates crosslinked by transglutaminases in liver and kidney fibrosis. Tatsukawa H; Takeuchi T; Shinoda Y; Hitomi K Anal Biochem; 2020 Sep; 604():113629. PubMed ID: 32061735 [TBL] [Abstract][Full Text] [Related]
17. Preferred substrate sequences for transglutaminase 2: screening using a phage-displayed peptide library. Hitomi K; Kitamura M; Sugimura Y Amino Acids; 2009 Apr; 36(4):619-24. PubMed ID: 18651094 [TBL] [Abstract][Full Text] [Related]
18. Identification of a preferred substrate peptide for transglutaminase 3 and detection of in situ activity in skin and hair follicles. Yamane A; Fukui M; Sugimura Y; Itoh M; Alea MP; Thomas V; El Alaoui S; Akiyama M; Hitomi K FEBS J; 2010 Sep; 277(17):3564-74. PubMed ID: 20716179 [TBL] [Abstract][Full Text] [Related]
19. Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2. Johnson KB; Petersen-Jones H; Thompson JM; Hitomi K; Itoh M; Bakker EN; Johnson GV; Colak G; Watts SW Am J Physiol Heart Circ Physiol; 2012 Apr; 302(7):H1355-66. PubMed ID: 22307675 [TBL] [Abstract][Full Text] [Related]